Skip to content Skip to footer
Vivos mmRNA appliance

Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

First Medicare-Accepted Oral Appliance Treatment for All Severities of Obstructive Sleep Apnea in Adults   LITTLETON, Colo., April 9, 2024 -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including all severities…

Read More

Vivos Releases 2023 4th Quarter Financial Results

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

March 28, 2024 16:05 ET | Source: Vivos Therapeutics, Inc Positive Business Momentum and Sales Pipeline Growth Following FDA 510(k) Clearance of Vivos’ Proprietary Oral Medical Devices to Treat Severe Obstructive Sleep Apnea Annual Operating Expenses Declined 27% Due to Success of Cost Cutting Initiatives Management to Host Conference Call Today at 5:00 pm ET LITTLETON,…

Read More

new technologies to treat Sleep Apnea

New Technologies To Treat Sleep Apnea

Sleep apnea is a widespread sleep disorder marked by pauses in breathing or shallow breaths during sleep, that affects countless individuals. These interruptions, which happen multiple times per hour, lead to fragmented sleep and decreased oxygen levels in the blood. Remarkably, in late 2023, Vivos Therapeutics received the first ever FDA 510(k) clearance for an…

Read More

alternative treatment to CPAP

Alternative Treatment To CPAP

Obstructive Sleep apnea is a prevalent sleep disorder that affects millions of people around the world, and manifests through pauses in breathing or shallow breaths when you sleep, disrupting sleep patterns and reducing blood oxygen levels. Thankfully, in November of 2023, Vivos achieved a milestone, receiving a first-of-its-kind FDA 510(k) clearance for an oral device…

Read More

2023 4th Quarter Financial Results

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call

Call Scheduled for Today, Thursday, March 28, 2024 at 5:00 pm ET March 28, 2024 07:30 ET | Source: Vivos Therapeutics, Inc LITTLETON, Colo., March 28, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective…

Read More

is sleep apnea genetic

Is Sleep Apnea Genetic?

Have you ever wondered, "Is sleep apnea genetic?" Maybe your dad snores loudly and stops breathing for a bit when he sleeps, and now you're doing the same. You're not alone in asking this question. Sleep apnea is a common sleep problem where people stop breathing for short periods during the night. Your family can play…

Read More